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The majority of the response of cytotoxic T-lymphocytes (CTL) to lymphocytic choriomeningitis virus (LCMV) in H-2d mice
is directed toward one epitope located on the nucleoprotein (NP, aa 118– 126), and usually no primary responses to
other epitopes are detectable. Previous studies have shown that thymic expression of lymphocytic choriomeningitis virus-
nucleoprotein (LCMV-NP) in H-2d transgenic mice (Thy-NP mice) leads to deletion of high-affinity anti-LCMV-NP CTL by
negative selection. Selection is incomplete, so that low-affinity NP-specific CTL pass through the thymus and are detectable
in the periphery. To analyze the importance of interferon-g (IFN-g) in the ability of low-affinity antiviral CTL to clear an acute
viral infection, double transgenic mice were generated that are IFN-g deficient and express the NP of LCMV in the thymus
(Thy-NP 1 IFN-g 0/0 mice). When infected with LCMV, these bigenic mice were unable to clear the infection despite
generating low-affinity primary antiviral CTL, and they became persistently infected. In contrast, IFN-g competent Thy-NP
mice cleared LCMV within 7 –8 days and IFN-g deficient mice that did not express NP in their thymus generated high-
affinity CTL that terminated an acute LCMV infection within 10 –12 days post-viral challenge. Persistently infected IFN-g
deficient mice selectively depleted LCMV-specific CTL and displayed reduced levels of antigen-presenting cells in the
spleen, and 60% of these mice died at 2–3 months postinfection. Thus, IFN-g is required for clearing an acute viral infection
in the absence of a high-affinity CTL response. In the absence of IFN-g persistent viral infection results despite the presence
of low-affinity CTL. q 1997 Academic Press
INTRODUCTION While both, T- and B-cell responses play important
roles in modulating virus infections, studies with agam-
Specific antiviral immunity is the function of T- and B-
maglobulinemic children show that T-cells are essential
cell responses. The repertoire of T- and B-lymphocytes in-
in the control of most viral infections. We and others
duced by viral infections consists of cells with varying re-
have used lymphocytic choriomeningitis virus (LCMV)2
ceptor affinities. Depending on the major histocompatibility infection in its natural host, the mouse, as a model to
complex (MHC) background of the host and the infecting
dissect the parameters involved in T-cell immunity (Buch-
virus, the immune response can be oligoclonal or poly-
meier et al., 1980; Borrow et al., 1996; Whitton et al.,
clonal (Buchmeier et al., 1980; Ahmed et al., 1984; Zinkerna-
1990). LCMV infection induces a strong response of cyto-
gel et al., 1978; Kagi et al., 1882; Klavinskis et al., 1989; von
toxic T-lymphocytes (CTL) in H-2d mice that is directed
Herrath et al., 1996). In general, a polyclonal high-affinity
mainly toward one immunodominant Ld restricted epi-
response is more effective in controlling a viral infection,
tope located on the viral nucleoprotein (NP), aa 118– 126.
preventing the generation of viral escape mutants, and pre-
Studies with LCMV in such H-2d mice indicate that, when
venting the establishment of a persistent infection (Westby
high-affinity CTL that normally control the viral infection
et al., 1996; Tishon et al., 1995; Jamieson et al., 1981; Ahmed
(Ahmed et al., 1984; Whitton et al., 1988; Zinkernagel
et al., 1984; Borrow et al., 1991; Lewicki et al., 1995). Studies
et al., 1993) are eliminated, lower-affinity CTL can still
have shown that part of the immune systems adaptability
mediate viral clearance (von Herrath et al., 1994a,b). In
is due to a ‘‘hierarchial’’ control of the immune response these investigations, LCMV-NP was expressed in the thy-
(Zinkernagel et al., 1978; Doherty et al., 1978; Allan et al.,
mus of H-2d transgenic mice (Thy-NP mice) and high-
1985; Lewicki et al., 1995; Oldstone et al., 1995). Accord-
affinity CTL were deleted in the thymus. Low-affinity CTL
ingly, lower-affinity T- or B-cell responses become more
escaped negative selection supporting the affinity/avidity
important in the control of a viral infection, when high-
model of thymic selection (Ashton-Rickardt et al., 1994;
affinity responses are compromised or deleted (von Herrath
et al., 1994).
2 Abbreviations used: APC, antigen-presenting cell; CTL, cytotoxic T-
lymphocytes; GP, glycoprotein; IFN-g, interferon-g; IgG, immunoglobu-
lin subclass G; ic, intracerebrally; ip, intraperitoneally; LCMV, lympho-1 To whom correspondence and reprint requests should be ad-
dressed at Department of Neuropharmacology, Division of Virology cytic choriomeningitis virus; m.o.i., multiplicity of infection; NP, nucleo-
protein; PBS, phosphate-buffered saline; TcR, T-cell receptor; tg,IMM6, The Scripps Research Institute, 10550 North Torrey Pines Road,
La Jolla, CA 92037. Fax: (619) 784-9981. E-mail: matthias@scripps.edu. transgenic.
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Sebzda et al., 1994) and trafficked to the periphery, where NP was detected in both groups of mice by PCR and no
indication for a difference in levels of expression wasthey could be detected. Such low-affinity CTL were func-
tional in vivo, because after activation by LCMV challenge noted. To obtain transgenic mice with a H-2d restricted
CTL response, Thy1.2-NP or RIP-NP mice were bred tothey caused autoimmune diabetes in transgenic mice
expressing the viral (NP) transgene in their b-cells (von the fifth generation with Balb/cByJ (H-2d) mice. As re-
ported elsewhere, RIP-NP IFN-g competent mice de-Herrath et al., 1994b).
Interferon-g (IFN-g) is an Th1-type cytokine that plays velop insulin-dependent diabetes mellitus (IDDM) follow-
ing infection with LCMV (von Herrath et al., 1994b),an intricate role in antiviral host defense mechanisms
and activation of cytotoxic T-cells (O’Garra et al., 1994; whereas RIP-NP IFN-g deficient mice never developed
IDDM. Development of IDDM neither interfered with theSwain 1994; Huang et al., 1993; Lee et al., 1995; Dalton
et al., 1993; Tishon et al., 1995; Flynn et al., 1993; Graham generation of primary or memory CTL nor interfered with
viral clearance.3et al., 1993). Further, IFN-g can enhance inflammatory
reactions and upregulate MHC molecules (Sarvetnick et As described earlier by us, LCMV-NP-specific RNA
al., 1990). Recent data indicate that IFN-g knock-out mice was detected in organs of Thy1.2-NP and RIP-NP
generate primary and memory CTL in response to LCMV transgenic mice using RT-PCR. In Thy1.2-NP tg mice,
infection with equivalent activities compared to those LCMV-NP RNA was expressed in the spleen, thymus,
found in IFN-g competent littermates (Tishon et al., 1995). Thy1.2-positive PBL (FACS sorted twice), and brain.
Generation of LCMV-specific primary CTL in IFN-g defi- LCMV-NP RNA was not found in Thy1.2-negative PBL, in
cient mice is able to terminate an acute viral infection pancreas, kidney, muscle, or liver obtained from Thy1.2-
(Tishon et al., 1995). In contrast, when memory CTL from NP tg mice (von Herrath et al., 1994a). RIP-NP transgenic
IFN-g knock-out mice are adoptively transferred into per- mice had restricted expression of NP RNA in their thymus
sistently infected recipients, virus is not cleared, showing and pancreas and not in other tissues (von Herrath et
that IFN-g is not required for activation of primary CTL al., 1994b). Despite multiple attempts using antibodies in
or control of acute infection by high-affinity CTL, but is immunohistochemical assays we were unable to detect
required for clearing a persistent infection by CTL (Tishon LCMV NP protein in the thymus, likely due to the small
et al., 1995). However, little is known about the require- amount of NP protein expressed and the need for
ment for IFN-g, if the antiviral response is dampened or 10,000 to 40,000 antigen molecules for antibody detec-
high-affinity CTL are absent. tion (Lerner et al., 1971). Both mouse lines, the Thy1.2
In this paper we examine the requirement for inter- NP mice and the RIP-NP mice were used in parallel for all
feron-g by low-affinity CTL in the control of an acute experiments presented in this report, unless otherwise
viral infection. We show that clearance of LCMV after indicated, and are referred to as Thy-NP (thymic ex-
challenge with a dose of 1 1 104 PFU or higher is totally pressors) transgenic mice. In direct comparison by RT-
dependent on the presence of IFN-g. In the absence of PCR, no differences in thymic expression of the
IFN-g, such mice become persistently infected. Over time transgene was noted. Further, numbers of low-affinity
they selectively deplete their LCMV-NP-specific CTL and CTL were very similar in both strains of mice (compare
antigen-presenting cells (APCs) in the spleen and death von Herrath et al., 1994a to von Herrath et al., 1994b).
occurs in 60% of the animals. Mice with a nonfunctional IFN-g gene on the H-2d
background were obtained from T. Stewart (Genentech
MATERIALS AND METHODS Inc., San Francisco, CA) (Dalton et al., 1993). Mice homo-
zygous for the mutation in the IFN-g gene (IFN-g defi-Generation of transgenic mice
cient or 0/0mice) housed at The Scripps Research Insti-
Transgenic mice that express the NP of LCMV in their tute under specific pathogen-free (SPF) conditions were
thymus (Thy1.2 NP line 6-6) were generated as described healthy and fertile.
(von Herrath et al., 1994a). Briefly, a vector utilizing the Double transgenic mice that express NP in their thy-
murine Thy1.2 gene was designed to express viral pro- mus and are IFN-g deficient were obtained by crossing
tein in the thymus. The Thy1.2 promoter directs higher IFN-g deficient mice with thymic expressors and then
expression of the transgenic RNA to the thymus than to intercrossing the LCMV-NP positive littermates from the
peripheral T-cells or fibroblasts (von Herrath et al., F1 generation that are all heterozygous for the IFN-g
1994a). Transgenic mice that express the NP of LCMV gene mutation. As a result IFN-g deficient (0/0) and
in the thymus and in their pancreas by use of the rat IFN-g (///) mice were obtained that did or did not ex-
insulin promoter (RIP-NP 25-3 mice) have been described press LCMV-NP in their thymus and were used in experi-
(Oldstone et al., 1991, von Herrath et al., 1994b) and mental and control groups.
were also used for the present study. All experiments
presented here were carried out in parallel with both
types of thymic expressor mice that are referred to in 3 von Herrath, M., and Oldstone, M. (1996). IFN-g is essential for
destruction of b-cells and IDDM. J. Exp. Med. in press.this article as Thy-NP mice. Thymic expression of LCMV-
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Biochemical studies 104 targets determined by correlating several E:T ratios
with the respective 51Cr release values. Killing of peptide-
Mice carrying the transgene were identified by hybrid- coated uninfected target cells by CTL followed our re-
ization of DNA extracted from their tails using an LCMV ported procedures (von Herrath et al., 1994a,b).
NP-specific probe (Oldstone et al., 1991; Dutko and Old- To determine CTL activity after secondary stimulation,
stone, 1982). RNA to be analyzed was extracted from spleen cells harvested from mice 30 – 120 days after pri-
their peripheral blood lymphocytes (PBL) and organs (thy- mary inoculation with 1 1 105 PFU LCMV ip were incu-
mus, brain, liver, muscle) by the guanidinium-isothiocya- bated with MHC-matched, irradiated, LCMV-infected
nate (GTC) method (von Herrath et al., 1994a,b). Prior to macrophages in the presence of T-cell growth factor and
PCR analysis of LCMV NP RNA, RNA samples were irradiated syngeneic spleen feeder cells (von Herrath et
treated with RNase-free RQ1 DNase to eliminate contam- al., 1995). For precursor frequency analysis, spleen cells
inating DNA. The RT-PCR was carried out as reported were harvested on Day 7, Day 14, and Day 60 after pri-
(von Herrath et al., 1994a,b) and PCR was run for 40 mary LCMV infection. These cells were diluted serially
cycles. LCMV NP-specific primers were 5* CAG TTA TAG and cultivated in 96-well flat-bottom plates in the pres-
GTG CTC TTC CGC 3* and 5* AGA TCT GGG AGC CTT ence of T-cell growth factor (supernatant from concanava-
GCT TTG 3*. Heterozygocity or homozygocity for the IFN- lin A stimulated rat splenocytes) and syngeneic irradiated
g knock-out defect was also tested by PCR. The wildtype LCMV infected (103 PFU/ml) spleen cells (105/well). After
IFN-g gene was detected by using primers AGAAGTAA- 9 days, each well was assayed for CTL lysis (described
GTG-GAAGGGCCCAGAAG and AGGGAAACTGGGAGA- above) on target cells that were uninfected or infected
GGAG-AAATAT, resulting in a 220-bp product and the with LCMV, Pichinde virus, VV/NP, or VV/GP. The fraction
mutant gene was detected by using primers TCAGCG- of negative cultures (lysis less than 11%) was determined
CAGGGGCGCC-CGGTTCTTT and ATCGACAAGACC- for each dilution (von Herrath et al., 1995, 1996).
GGCTTCCATCCGA, resulting in a 190-bp product. The phenotype of surface molecules expressed on
lymphocytes was determined by incubating cells with
Virologic and immunologic studies monoclonal antibodies to murine CD4 (rat monoclonal
antibody YTS 191.1.1), CD8 (rat monoclonal antibody YTSVirus stocks consisted of LCMV ARM (clone 53b), Pich-
169.4.2), or monoclonal antibody Thy1.2 (Pharmingen,inde virus, and vaccinia virus (V V) recombinants that ex-
San Diego, CA) for 30 min followed by incubation withpressed LCMV-NP (V V/NP) aa 1– 558 (Oldstone et al.,
mouse anti-rat Ig FITC reagent (von Herrath et al., 1994,1988; Klavinskis et al., 1990). Virus was plaque-purified
1996). Quantitation or sorting was by FACS (Oldstone etthree times on Vero cells and virus stock prepared by a
al., 1991). Presence and quantitation of LCMV-specificsingle passage on BHK-21 cells. Viral titers were as-
antibody was recorded by a solid-phase enzyme-linkedsessed by plaque assay (Tishon et al., 1995). Briefly,
immunoabsorbent assay (ELISA) (Buchmeier et al., 1981).monolayers of Vero cells were infected with different
Antibodies to LCMV NP in sera of transgenic mice weredilutions of mouse sera or tissue homogenates and
also defined using [35S]methionine-labeled LCMV-in-plaques were counted 5 days later. Stocks of recombi-
fected BHK cells, immune precipitation, and SDS– PAGEnant vaccinia viruses were prepared by infection of 143
(Buchmeier et al., 1981).TK0 cells in medium containing bromodeoxyuridine
(Whitton et al., 1989). MC57 (H-2b) and Balb/Cl7 (H-2d) Immunohistochemical studies
cells were grown in culture and used as CTL targets Spleens were removed and quick-frozen in O.C.T. com-
(Whitton et al., 1989). pound, after which 6- to 10-mm sections were cut, mounted
To determine CTL activity toward infected target cells, on superfrost plus glass slides (Fisher Scientific, Pittsburgh,
splenic CTL were obtained from mice 7 days after ip PA), fixed, and stained as reported (von Herrath et al., 1995).
inoculation of 1 1 105 PFU of LCMV (Oldstone et al., Primary antibodies were rat anti-mouse L3T4, rat anti-
1991). Effector:target (E:T) ratios used were 100:1, 50:1, mouse Ly2 and Ly3, MHC class I, MHC class II (Phar-
25:1, 12:1, and 6:1 for splenic CTL, and 10:1, 5:1, 2:1, and mingen), F4/80 (Serotec), NLDC 145 (Serotec), and MAC-1
1:1 for CTL clones. Target cells (MC57/H-2b, BalbCl7/H- (Boehringer, La Jolla, CA). Secondary antibody was biotinyl-
2d) were infected with LCMV for 1 hr at 377 (multiplicity ated goat anti-rat IgG (Boehringer Mannheim, La Jolla, CA).
of infection (m.o.i.) of 1) or with VV/LCMV recombinants Hematoxylin– eosin stains were carried out on paraffin-em-
for 1 hr (m.o.i. of 3). Forty-eight (LCMV) or 12 hr (V V) after bedded tissues fixed with Bouin’s fixative.
infection, cells were labeled with 51Cr. Incubation of virus
RESULTSinfected or uninfected 51Cr-labeled targets with splenic
Thy-NP transgenic mice make low-affinity CTL andCTL or CTL clones (Klavinskis et al., 1989) lasted for 5
are not capable of clearing LCMV infection in thehr, after which supernatant was collected and the amount
absence of interferon-gof chromium released was measured. Lytic units (LU)
were defined as the reciprocal of the number of effector As described previously (von Herrath et al., 1994a,b),
mice that express the viral NP in their thymus (RIP-NPcells among 106 splenocytes required for 25% lysis of
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or Thy1.2 NP) make low-affinity CTL following a primary Thy-NP IFN-g deficient mice developed ruffled fur and a
hunched appearance 6– 8 weeks post-LCMV infection, ac-LCMV infection. Affinity of CTL from Thy-NP transgenic
mice that were either IFN-g competent or deficient was companied by a 20– 40% loss of their body weight, and by
3 months postinfection 60% of these mice had died. Thus,assessed by two techniques: First, target cells were
coated in vitro with molar dilutions of peptides recog- low-affinity CTL are unable to clear a virus infection in the
absence of IFN-g, an infection that is eliminated in thenized by LCMV-NP CTL on the H-2d background, and
second, different amounts of anti-CD8 antibody were presence of IFN-g.
added to block CTL activity. As displayed in Fig. 1A, IFN-
LCMV clearance in Thy-NP transgenic mice that lackg deficient mice without expression of LCMV-NP in the
IFN-g is dependent on the viral dosethymus made equivalent high-affinity CTL responses
compared to normal Balb/c (H-2d) mice. In contrast, IFN-
Next, we examined whether the inability of low-affinity
g deficient and competent Thy-NP transgenic mice (RIP-
CTL to clear LCMV infection in the absence of IFN-gNP, data shown and Thy1.2 NP, data not shown) both
was dependent on viral dose. Groups of five Thy-NP IFN-made equivalent low-affinity CTL responses. Results for
g-deficient mice were given 102, 103, 104, and 105 PFUaffinity testing of these various CTL populations are
LCMV ip. As shown in Table 1, viral clearance was de-shown in Figs. 1B and 1C. Less anti-CD8 antibody was
pendent on the inoculated dose. When doses of 103 PFU
required to block the low-affinity CTL activities of Thy-
or lower were given, at least 3 logs of virus was cleared
NP IFN-g deficient (0/0) and competent (/// or //0)
in the absence of IFN-g. In contrast, mice inoculated withmice than to inhibit high-affinity CTL made by Balb/c IFN-
doses of 104 PFU or higher of LCMV were not able to
g deficient (0/0) or competent (/// or //0) mice (Fig.
terminate the infection and maintained 4 to 6 logs of virus1B). Greater amounts of the H-2d restricted LCMV-NP
(Table 1). Thus, low-affinity CTL need IFN-g to eliminatepeptide (RPQASGVYM) were required to lyse target cells
larger amounts of virus. When smaller amounts of viruswith low-affinity CTL from IFN-g deficient or competent
are used to initiate infection, IFN-g is not required formice with thymic expression than needed for CTL from
viral clearance.nonthymic expressor mice (Fig. 1C). Thus, the lack of
IFN-g expression does not influence the generation of
Persistently infected Thy-NP IFN-g-deficient mice
primary high- or low-affinity CTL following LCMV in-
selectively deplete LCMV-specific CTL
fection.
Next we tested, whether IFN-g deficient low-affinity CTL Table 2 compares the numbers of LCMV-specific
clear acute LCMV infection like IFN-g competent low-affin- (memory) CTL generated in Thy-NP IFN-g competent
ity CTL do. In the experiment shown in Fig. 2, Thy-NP IFN- compared to Thy-NP IFN-g deficient mice. Whereas nor-
g deficient or competent (Thy-NP IFN-g //0 or 0/0) and mal and IFN-g deficient mice or Thy-NP transgenic mice
normal IFN-g deficient or competent mice (Balb/c IFN-g generated good levels of LCMV-specific memory CTL
/// or 0/0) were each given 1 1 105 PFU LCMV ip. (precursor frequency average 1/1500), LCMV-specific
Serum viral titers were assessed every 2 weeks and the memory CTL were not detected in Thy-NP IFN-g deficient
health of all animals was monitored on a twice-weekly (0/0) mice. This finding stands in contrast to the genera-
basis. Low-affinity CTL from IFN-g deficient Thy-NP mice tion of primary CTL in Thy-NP IFN-g deficient mice (Fig.
were unable to clear LCMV infection over a 2- to 3-month 1). Table 2 also shows that stimulation of splenocytes
observation period. By contrast, the other three groups of harvested from persistently infected Thy-NP IFN-g defi-
mice [Thy-NP IFN-g //0 and Balb/c IFN-g 0/0 or IFN-g cient mice 60 days post-LCMV infection could not be
stimulated in vitro in the presence of IL-2 (T-cell growth///] cleared LCMV within 7–12 days. Persistently infected
FIG. 1. Thy-NP 1 IFN-g deficient or IFN-g competent transgenic mice generate similar levels of low-affinity primary CTL following LCMV infection.
(A) Analysis of LCMV NP-specific CTL generated in the spleens of IFN-g deficient or competent nontransgenic H-2d control (l, h) or Thy-NP H-2d
tg (s, j) mice. Bar represents 2 SE for each time point. Targets were 51Cr-labeled Balb/Cl7 (H-2d) fibroblasts infected with vaccinia virus/LCMV
NP recombinant. H-2 restriction occurred, as killing of similarly infected H-2b targets did not cause 51Cr release. Four to five mice were used per
group. See Materials and Methods for CTL assay. (B) Less antibody to CD8 (monoclonal GK1.5) is required to inactivate CD8/ LCMV NP-specific
CTL obtained from IFN-g competent or deficient Thy-NP H-2d mice (s, j) and then from age- and sex-matched non-tg IFN-g competent or deficient
controls (l, h). Bar indicates 2 SE. Four to five mice were used per group. Monoclonal antibody to CD8 at different dilutions was incubated with
the CD8/ effector cells. E:T ratios used were 50:1 and 25:1 with data from 50:1 shown. (C) Thy-NP H-2d tg mice (s, j) generate LCMV NP-specific
CTL with less affinity than NP-specific CTL made by age- and sex-matched non-tg controls (l, h). The NP sequence for which H-2d CTL are
restricted is RPQASGVYM(G). Differing concentrations of this peptide were used to coat 51Cr-labeled H-2d Balb/Cl7 fibroblasts, and the mixture was
incubated with CTL at E:T ratios of 50:1 and 25:1 with data from 50:1 shown. Coating of H-2b 51Cr-labeled targets with this peptide did not result
in cell lysis. Bar indicates 2 SE for four to five mice used per each group. See Materials and Methods for 51Cr release assay. Numbers of CTL
precursors were determined in IFN-g competent or deficient Thy-NP tg mice and non-tg littermates. Analysis was performed as described under
Materials and Methods. Positive cultures showed a specific lysis of 11%. Activity of CTL from Thy-NP tg mice or nontransgenic mice was tested
on LCMV-infected targets. No significant differences were found in numbers of primary CTL in all groups of mice tested (data not shown).
AID VY 8442 / 6a2a$$$281 02-18-97 14:10:54 vira AP: Virology
354 VON HERRATH, COON, AND OLDSTONE
FIG. 2. Thy-NP 1 IFN-g deficient double transgenic mice do not clear LCMV and develop a persistent viral infection. Groups of 10 nontransgenic
IFN-g deficient or competent and Thy-NP transgenic IFN-g deficient or competent mice were injected with 1 1 105 PFU LCMV ip and viral titers
were assessed in serum (PFU/ml) and spleens (PFU/spleen) by plaque assay (see Materials and Methods). The graph displays the mean titer {
1 SE. The first time-point is Day 1 postinfection. All Thy-NP IFN-g deficient mice developed persistent infection with LCMV over a 3-month observation
period and the majority (60%) died after 3 months.
factor, TCGF) to generate LCMV-NP- or GP-specific CTL. termates that had cleared LCMV. Based on these find-
ings we conclude that the selective depletion of LCMV-In contrast, memory CTL to a different unrelated virus
(Pichinde) given prior to LCMV infection were made in specific CTL found in persistently infected Thy-NP IFN-
g deficient mice is not due to the induction of anergythese mice (Table 2). Further, overall numbers of CD8/
lymphocytes in spleens and blood were not significantly (Harding et al., 1992), since lymphocytes could not be
activated in the presence of IL-2 and antigen in vitro andreduced at 60 days post-LCMV in Thy-NP persistently
infected mice as compared to IFN-g competent lit- CTL activities are lost irrevocably.
TABLE 1
Viral Clearance of LCMV in Thy-NP IFN-g Deficient Mice Is Dependent on the Viral Dose
Day 7 Day 14 Day 60
Infected with
Mouse group (H-2d) log(PFU) of LCMV CTLa Virusb CTLa Virus b CTLa Virusb
Non-tg 5 65 { 8% 3 1 102 { 200 20 { 4% — 53 { 4% —
IFN-g competent 3 72 { 6% 103 { 300 12 { 8% — 48 { 7% —
Non-tg 5 64 { 3% 104 { 2000 10 { 6 — 49 { 2% —
IFN-g deficient 3 62 { 9% 103 { 750 8 { 2% — 38 { 13% —
Thy-NP 5 20 { 9%c 103 { 200 9 { 3% — 20 { 4%c —
IFN-g competent 3 12 { 7%c 3 1 104 { 1500 5 { 3% — 30 { 6%c —
Thy-NP 5 20 { 5%c 2 1 105 { 8800 0% 2 1 106 { 105 0% 8 1 105 { 105
IFN-g deficient 4 18 { 6%c 5 1 105 { 3 1 105 0% 3 1 105 { 105 0% 4 1 104 { 104
3 23 { 6%c 3 1 104 { 2 1 104 5 { 3% 102 { 102 30 { 4%c —
2 17 { 4%c 3 1 102 { 2 1 102 3 { 1% — 22 { 7%c —
Note. Clearance of LCMV in Thy-NP 1 IFN-g deficient double transgenic mice is dependent on the viral dose. Groups of five nontransgenic
IFN-g deficient or competent and Thy-NP transgenic IFN-g deficient or competent mice were injected with 102, 103, 104, and 1 1 105 PFU
LCMV ip and viral titers were assessed in serum (data shown) and spleens (data not shown) by plaque assay (see Materials and Methods).
All Thy-NP IFN-g deficient mice injected with 104 PFU or more developed persistent infection with LCMV over a 2- to 3-month observation
period. CTL activities and precursor frequencies of CTL were assessed as described under Materials and Methods. ( —) indicates that no
virus (PFU/ml serum) was detectable.
a CTL activity is percentage of 51Cr release from LCMV-infected syngeneic targets.
b Viral titer is plaque-forming units per milliliter of serum.
c Low-affinity CTL (von Herrath et al., 1994a,b).
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TABLE 2
Thy-NP IFN-g Deficient Mice Deplete LCMV-Specific Memory CTL Following LCMV Infection
Precursor frequency of CTL killing targets
Secondary effector Day 60
splenocytes H-2d
Group H-2d mice Virus given Experiment LCMV vv/GP NPpep Pichinde
Non-tg LCMV 1 1/1,000 1/50,000 1/2,500 1/50,000
IFN-g competent 2 1/853 1/50,000 1/3,048 1/50,000
Non-tg LCMV 1 1/4,000 1/50,000 1/4,500 1/50,000
IFN-g deficient 2 1/3,500 1/50,000 1/6,000 1/50,000
Thy-NP LCMV 1 1/2,300 1/8,000 1/1,900 1/50,000
IFN-g competent 2 1/905 1/9,400 1/2,350 1/50,000
38 { 9%a 20 { 6%a 30 { 8%a 2 { 4%a
Thy-NP LCMV 1 1/50,000 1/50,000 1/50,000 1/50,000
IFN-g deficient 2 1/50,000 1/50,000 1/50,000 1/50,000
Thy-NP Pichinde 1 1/50,000 1/50,000 1/50,000 1/2,000
IFN-g deficient 2 1/50,000 1/50,000 1/50,000 1/4,560
Thy-NP LCMV 1 1/50,000 1/50,000 1/50,000 1/50,000
IFN-g deficient 4 { 2%a 0a 0a 2 { 1%a
Note. LCMV-specific memory CTL are selectively lost in persistently infected Thy-NP IFN-g deficient mice. Secondary CTL were recovered from
spleens of persistently infected IFN-g deficient Thy-NP mice, single transgenic Thy-NP mice that cleared LCMV infection (see also Fig. 2), and
nontransgenic IFN-g deficient or competent controls, two mice per group. CTL activity was tested on syngeneic LCMV-infected or uninfected target
cells after 5– 14 days of in vitro stimulation (see Materials and Methods) and precursor frequency analysis was performed as described (Materials
and Methods). One group of mice was infected simultaneously to LCMV infection with an equivalent dose of Pichinde virus. Activities of Pichinde
virus-specific CTL were measured as described on Pichinde virus-infected syngeneic target cells. Two mice were analyzed per group and means
{ 1 SE are shown.
a Percentage of 51Cr release in a CTL assay after a 14-day secondary stimulation of CTL in vitro in the presence of TCGF (IL-2) measured in
cultures set up in a parallel to the precursor frequency analysis, E:T ratio  5:1.
Numbers of antigen-presenting cells are significantly trol mice at Day 45 post-LCMV. Further, when spleens
from IFN-g deficient or competent Thy-NP mice werereduced in spleens of persistently infected Thy-NP
transgenic IFN-g deficient mice analyzed histologically prior to LCMV infection, there
were no detectable differences in the appearance of theWe next evaluated whether a defect in antigen presen-
red pulp or numbers of F4/80/MAC-1-positive cells be-tation was associated with the inability to clear virus.
tween the two groups. Thus, persistently infected IFN-gHistological analysis was performed on spleens derived
deficient Thy-NP mice selectively lose a major part ofon Day 45 after infection from persistently infected IFN-
their APC repertoire in the spleen and lack class I and
g deficient Thy-NP mice and was compared to analysis
class II expression in the area of the red pulp.of spleens from Thy-NP mice that cleared virus (Fig. 3).
The marginal zones of the spleen (red pulp) are markedly
DISCUSSION
reduced in size (Fig. 3, top and middle left panels com-
pared to top and middle right panels). In addition very In this report we demonstrate that low-affinity CTL gen-
erated in tg mice expressing a viral antigen in the thymusfew F4/80-positive macrophages were detected in the
red pulp (Fig. 3 bottom left panel compared to lower right (Thy-NP) need IFN-g to eliminate acute LCMV infection
in a dose-dependent manner. Infection with viral dosespanel) of Thy-NP IFN-g 0/0 mice. In other studies cells
bearing the APC marker MAC-1 (macrophages) and greater than 104 PFU results in persistent viral infection
in IFN-g deficient Thy-NP mice. In contrast, low-affinityNLDC-145 (dendritic cells) were found to be reduced to
a comparable degree, like the F4/80-positive cells shown CTL do not require IFN-g to terminate a lower level of
LCMV infection initiated with 103 PFU or less. Althoughin Fig. 3 (bottom right panel), and expression of MHC
class II molecules and class I molecules was not detect- antiviral low-affinity primary CTL are initially generated
in interferon-g-deficient Thy-NP tg mice following LCMVable in the area of the red pulp of spleens from persis-
tently infected mice (data not shown). In contrast, normal infection, they are selectively depleted over time and
antigen-presenting cells in the spleen are significantlylevels of dendritic (NLDC-145/) cells, macrophages (F4/
80/), and MHC class II and I expression were noted reduced. As a consequence, persistent infection occurs
in all mice but leads to death in 60%.throughout the spleens of Thy-NP IFN-g competent con-
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FIG. 3. Thy-NP tg mice that generate low-affinity CTL do not clear LCMV in the absence of IFN-g and deplete F 4/80 positive APC in their spleens
over time. Spleens from persistently infected Thy-NP 1 IFN-g deficient mice compared to spleens from Thy-NP IFN-g competent mice that cleared
LCMV show depletion of APCs in the red pulp region. (Top and middle panels, left) Spleen from Thy-NP mouse on Day 45 post-LCMV infection;
hematoxylin/eosin stain. (Top and middle panels, right) Spleen from Thy-NP 1 IFN-g deficient mouse on Day 45 post-LCMV; hematoxylin/eosin
stain. (Bottom panel, left) Spleen from Thy-NP mouse on Day 45 post LCMV infection; hematoxylin and F4/80 stain. (Bottom panel, right) Spleen
from Thy-NP 1 IFN-g deficient mouse on Day 45 post-LCMV, hematoxylin and F4/80 stain. Immunohistochemistry was performed as described
under Materials and Methods. Sections displayed are representative of findings determined in six other mice for each panel.
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Several parameters play a role in the development of vation (Tough et al., 1996). However, this possibility
seems unlikely, because memory to other viruses suchpersistent LCMV infection. First, the viral dose is im-
portant. Dosages higher than 107 PFU can lead to persis- as Pinchinde is maintained (Table 2) and, additionally,
the overall number of CD8/ lymphocytes found intent infection even in normal immunocompetent mice
(Moskophidis et al., 1993). Doses 104 PFU lead to per- spleens or peripheral blood of persistently infected Thy-
NP IFN-g 0/0 mice is comparable to numbers usuallysistent infection in IFN-g deficient Thy-NP mice that gen-
erate low-affinity CTL (Table 1). Doses lower than 104 detected in Thy-NP transgenic or nontransgenic mice
that cleared LCMV. A second and perhaps more likelyPFU do not result in persistent infection in any of the
mice tested, unless CTL activity is absent as for example possibility is that persistence of virus that occurs in Thy-
NP IFN-g deficient mice leads to chronic activation ofin CD8 knockout (Lehmann-Grube et al., 1993; Borrow et
al., 1996) or perforin knock-out mice (Kagi, 1994b).4 Sec- CTL followed by their depletion. The mechanism for how
this occurs is at present unclear. Several investigatorsond, the level of IFN-g produced is important. Viral clear-
ance mediated by antiviral CTL can occur in the absence have reported that CTL can be depleted when viral anti-
gen is present in excess or for a prolonged period ofof IFN-g when high-affinity CTL are present. In contrast,
when low-affinity CTL are generated, IFN-g is also re- time presumably leading to activation-induced apoptotic
cell death (Selin and Welsh, 1994; Zinkernagel, 1993a,b).quired for the control of the infection. LCMV infection
leads to presentation of viral antigens by professional By this scenario, during persistent infection, virus might
be displayed on many ‘‘nonprofessional’’ APCs in additionAPCs that activate CTL in the presence and in the ab-
sence of IFN-g. When the CTL are of high affinity, they to ‘‘professional’’ APCs such as dendritic cells, macro-
phages or B-cells, so that virus-specific CTL readily en-lyse cells expressing viral antigens, thereby eliminating
virus and terminating the infection after 6– 8 days. In counter antigen without presumably receiving the re-
quired costimulatory signals provided by professionalthis case the antiviral effect of IFN-g plays a minor role.
However, when low-affinity CTL are generated, fewer APCs (Matzinger, 1994; King and Ashwell, 1993) and
therefore undergo apoptosis more readily (Harding andcells expressing viral antigen are killed, probably be-
cause IFN-g deficient mice are not able to upregulate Allison, 1993; Matzinger, 1994). However, this issue is
controversial. Virus-infected cells can activate T-lympho-MHC molecules needed for antigen presentation. In IFN-
g competent mice, MHC is upregulated and viral clear- cytes in the absence of costimulation by B7 (Scholz et
al., 1996). In the Thy-NP IFN-g deficient mice reportedance occurs even with low-affinity CTL. Studies by others
have demonstrated the importance of IFN-g mediated here (Fig. 2), low-affinity CTL might not kill enough cells
containing replicating virus, and therefore virus persists.direct antiviral effects in the elimination of certain chronic
viral infections (Guidotti et al., 1996a,b). Concurrently, professional APCs would continue to acti-
vate antiviral low-affinity CTL and these would continueWe (von Herrath et al., 1994a,b), and others (Ashton-
Rickardt et al., 1994; Heath et al., 1992) showed that to kill cells expressing viral antigen. Because IFN-g is
absent, viral clearance is achieved and this spiral contin-low-affinity CTL escape negative selection in the thymus
(Sprent, 1990; Pircher et al., 1991), supporting the con- ues and presumably leads to decreased levels of APCs
in the spleen as observed in Thy-NP IFN-g deficient micecept of affinity dependence of thymic selection. Thus,
following LCMV infection, low-affinity primary and mem- (Fig. 3).
Most important, the model described here illustratesory CTL are not deleted but traffic to the periphery in
Thy-NP transgenic mice (von Herrath et al., 1994a,b). how the kinetics of infection are modulated by an inter-
play of several factors. The outcome of clearance, sur-Further, these thymic expressor H-2d mice generate an
alternative, novel response to the glycoprotein (GP) of vival, persistence, or death following viral infection is
determined by the interaction of these elements.LCMV. IFN-g deficient mice with expression of LCMV-
NP in their thymus also generate primary low-affinity Events as analyzed and described in this report may
well occur in several chronic human viral infections.LCMV-NP-specific CTL (Tishon et al., 1995; Fig. 1). Given
these data it is surprising that both NP- and GP-specific For example, in the later stages of HIV infection the
loss of CD4 T-lymphocytes and decline of CTL (CD8)(memory) CTL are not detectable in Thy-NP IFN-g-defi-
cient mice, while in contrast good levels of LCMV mem- activities may reflect a loss of IFN-g required to main-
tain CTL and CD8 memory (Tishon et al., 1995). Theory CTL are present in Thy-NP IFN-g competent mice
(Table 2) and in IFN-g deficient mice that do not express remaining CTL might be unable to control viral load
yet still participate in ongoing immune activation. Un-NP in their thymus (Table 2). Two explanations might
account for this defect in the generation and/or mainte- derstanding the fine-tuned interplay of these factors
will likely help to predict the outcome of an infectionnance of CTL. First, IFN-g could be required for main-
taining low-affinity (memory) CTL through bystander acti- and be helpful in designing appropriate intervention
strategies to combat persistent viral infections in hu-
mans infected with hepatitis B virus, human immuno-4 H. Lewicki, B. Coon, and M. B. A. Oldstone, unpublished observa-
tions. deficiency virus, or cytomegalovirus.
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